191 related articles for article (PubMed ID: 21158016)
1. Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole.
Bäckström P; Etelälahti TJ; Hyytiä P
Addict Biol; 2011 Jan; 16(1):55-63. PubMed ID: 21158016
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.
Sørensen G; Sager TN; Petersen JH; Brennum LT; Thøgersen P; Hee Bengtsen C; Thomsen M; Wörtwein G; Fink-Jensen A; Woldbye DP
Psychopharmacology (Berl); 2008 Jul; 199(1):37-46. PubMed ID: 18481046
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
[TBL] [Abstract][Full Text] [Related]
4. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
Schwabe K; Koch M
Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
[TBL] [Abstract][Full Text] [Related]
5. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
[TBL] [Abstract][Full Text] [Related]
6. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
Bergman J
Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
[TBL] [Abstract][Full Text] [Related]
7. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.
Wee S; Wang Z; Woolverton WL; Pulvirenti L; Koob GF
Neuropsychopharmacology; 2007 Oct; 32(10):2238-47. PubMed ID: 17327886
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
Leite JV; Guimarães FS; Moreira FA
Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
[TBL] [Abstract][Full Text] [Related]
9. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
Stoops WW; Lile JA; Glaser PE; Rush CR
Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.
Mavrikaki M; Nomikos GG; Panagis G
Int J Neuropsychopharmacol; 2010 May; 13(4):541-8. PubMed ID: 20047715
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
Stoops WW
Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole attenuates established behavioral sensitization induced by methamphetamine.
Futamura T; Akiyama S; Sugino H; Forbes A; McQuade RD; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1115-9. PubMed ID: 20561555
[TBL] [Abstract][Full Text] [Related]
14. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions.
Fletcher PJ; Korth KM; Chambers JW
Psychopharmacology (Berl); 1999 Sep; 146(2):185-93. PubMed ID: 10525754
[TBL] [Abstract][Full Text] [Related]
15. The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice.
Jerlhag E
Alcohol; 2008 Mar; 42(2):123-7. PubMed ID: 18358991
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats.
Thomsen M; Fink-Jensen A; Woldbye DP; Wörtwein G; Sager TN; Holm R; Pepe LM; Caine SB
Psychopharmacology (Berl); 2008 Nov; 201(1):43-53. PubMed ID: 18612628
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.
Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
Neuropharmacology; 2012 Feb; 62(2):765-74. PubMed ID: 21925189
[TBL] [Abstract][Full Text] [Related]
18. Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.
Nordquist RE; Risterucci C; Moreau JL; von Kienlin M; Künnecke B; Maco M; Freichel C; Riemer C; Spooren W
Neuropharmacology; 2008 Feb; 54(2):405-16. PubMed ID: 18054053
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole acts as a selective dopamine D2 receptor partial agonist.
Wood M; Reavill C
Expert Opin Investig Drugs; 2007 Jun; 16(6):771-5. PubMed ID: 17501690
[TBL] [Abstract][Full Text] [Related]
20. Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
Di Clemente A; Franchi C; Orrù A; Arnt J; Cervo L
Addict Biol; 2012 Mar; 17(2):274-86. PubMed ID: 21521422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
